ATP III Guidelines Detection and Evaluation

Apr 26, 2013

140 likes | 432 Views

Categories of Risk Factors. Major, independent risk factorsLife-habit risk factorsEmerging risk factors. Life-Habit Risk Factors. Obesity (BMI ? 30)Physical inactivityAtherogenic diet. Emerging Risk Factors. Lipoprotein (a)HomocysteineProthrombotic factorsProinflammatory factorsImpaired fasting glucose Subclinical atherosclerosis.

Share Presentation

Embed Code

Link

Ava

Download Presentation

ATP III Guidelines Detection and Evaluation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

atp iii guidelines adherence

Interventions to Improve Adherence. Focus on the patientSimplify medication regimensProvide explicit patient instruction and use good counseling techniques to teach the patient how to follow the prescribed treatmentEncourage the use of prompts to help patients remember treatment regimensUse systems to reinforce adherence and maintain contact with the patient.

616 views • 5 slides

ATP III Guidelines Drug Therapy

Drug Therapy. HMG CoA Reductase Inhibitors (Statins)Reduce LDL-C 18

509 views • 18 slides

NCEP ATP III Cholesterol Guidelines and Updates

NCEP ATP III Cholesterol Guidelines and Updates. Anoop Agrawal, M.D. Med-Peds Continuity Clinic Baylor College of Medicine. Background. Adult Treatment Panel of the National Cholesterol Education Program issued their third guideline for cholesterol management in 2001 - known as ATP III .

933 views • 26 slides

ATP III Guidelines Population Groups

Special Considerations for Different Population Groups. Younger AdultsMen 20

212 views • 6 slides

Adult Treatment Panel III ATP III Guidelines Erminia Guarneri, MD, FACC October 2001

New Features of ATP III. Focus on Multiple Risk FactorsDiabetes: CHD risk equivalentFramingham projections of 10-year CHD riskIdentify certain patients with multiple risk factors for more intensive treatmentMultiple metabolic risk factors (metabolic syndrome)Intensified therapeutic lifestyle changes.

940 views • 67 slides

ATP III Guidelines Therapeutic Lifestyle Changes TLC

Therapeutic Lifestyle Changes in LDL-Lowering Therapy. Major FeaturesTLC DietReduced intake of cholesterol-raising nutrients (same as previous Step II Diet)Saturated fats <7% of total caloriesDietary cholesterol <200 mg per dayLDL-lowering therapeutic optionsPlant stanols/sterols (2 g per day)Viscous (soluble) fiber (10

444 views • 7 slides

Chapter 3. Community Detection and Evaluation

Chapter 3. Community Detection and Evaluation. May 2013 Youn-Hee Han http://link.koreatech.ac.kr. Prologue. Community Detection Social networks demonstrate a strong community effect Actors in a network tend to form closely-knit groups

445 views • 16 slides

Community Detection and Evaluation

Community Detection and Evaluation. Chapter 3. Community. Community : It is formed by individuals such that those within a group interact with each other more frequently than with those outside the group a.k.a. group , cluster , cohesive subgroup , module in different contexts

793 views • 46 slides

Assessment and Evaluation, Part III: Evaluation Processes

Assessment and Evaluation, Part III: Evaluation Processes. Week 12. SMART Notebook Quizzes. SMART quizzes. Bryan will pass out the SMART response clickers Each of you will be assigned the following number: Lugassy , Stefanie Scheckelhoff , Renae Marr, Clifford

522 views • 33 slides

ATP III Guidelines Goals and Treatment Overview

ATP III Guidelines Goals and Treatment Overview. Primary Prevention With LDL-Lowering Therapy. Public Health Approach Reduced intakes of saturated fat and cholesterol Increased physical activity Weight control. Primary Prevention . Goals of Therapy Long-term prevention (>10 years)

284 views • 17 slides

ATP III Guidelines Detection and Evaluation

ATP III Guidelines Detection and Evaluation. Categories of Risk Factors. Major, independent risk factors Life-habit risk factors Emerging risk factors. Life-Habit Risk Factors. Obesity (BMI  30) Physical inactivity Atherogenic diet. Emerging Risk Factors. Lipoprotein (a) Homocysteine

327 views • 14 slides

ATP III Guidelines Drug Therapy

ATP III Guidelines Drug Therapy. Drug Therapy. HMG CoA Reductase Inhibitors (Statins) Reduce LDL-C 18–55% & TG 7–30% Raise HDL-C 5–15% Major side effects Myopathy Increased liver enzymes Contraindications Absolute: liver disease Relative: use with certain drugs.

389 views • 19 slides

ATP III Guidelines Specific Dyslipidemias

ATP III Guidelines Specific Dyslipidemias. Specific Dyslipidemias: Very High LDL Cholesterol ( 190 mg/dL). Causes and Diagnosis Genetic disorders Monogenic familial hypercholesterolemia Familial defective apolipoprotein B-100 Polygenic hypercholesterolemia

363 views • 13 slides

Finger detection evaluation system

Finger detection evaluation system. Su-ting, Chuang. Outline. Introduction Related work Hardware configuration Finger Detection system Optimal parameter estimation framework Conclusion. Outline. Introduction Related work Hardware configuration Finger Detection system

384 views • 29 slides

Adult Treatment Panel III (ATP III) Guidelines

Adult Treatment Panel III (ATP III) Guidelines. National Cholesterol Education Program. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (ATP III). Members Scott M. Grundy, M.D., Ph.D. (Chair)

939 views • 11 slides

CEPEJ Guidelines , Studies and Evaluation Tools

CEPEJ Guidelines , Studies and Evaluation Tools. CEPEJ Guidelines. Guidelines of the CEPEJ CE PEJ(2013)7RevE / 06 December 2013 Guidelines on the Creation of Judicial Maps to Support Access to Justice within a Quality Judicial System CEPEJ(2008)8RevE / 25 September 2013

326 views • 15 slides

SUPPLIER EVALUATION GUIDELINES

SUPPLIER EVALUATION GUIDELINES. SUPPLIER EXCELLENCE. MONTHLY SUPPLIER SCORECARD. MONTHLY SUPPLIER SCORECARD. Part Production Approval Process (PPAP).

403 views • 6 slides

UKOER III synthesis and evaluation

UKOER III synthesis and evaluation. Allison Littlejohn, Lou McGill Helen Beetham, Isobel Falconer Caledonian Academy Glasgow Caledonian University, UK www.academy.gcal.ac.uk. Vision. Extending reputation. Who we are: Evaluation and Synthesis Team. Allison Littlejohn

201 views • 9 slides

ATP III Guidelines Implementation

ATP III Guidelines Implementation. Percent of Adults Who Need Lifestyle and Drug Treatment. CHD and CHD Risk Equivalents 12.1 10.5 10-year risk >20% 2+ Risk Factors 5.5 4.2 10-year risk 10-20% 2+ Risk Factors 7.4 1.4 10-year risk <10% 0-1 Risk Factor 7.9 2.4

176 views • 5 slides

Implications of Recent Clinical Trials for the NCEP ATP III Guidelines

Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

423 views • 16 slides

ATP III Guidelines Therapeutic Lifestyle Changes (TLC)

ATP III Guidelines Therapeutic Lifestyle Changes (TLC). Therapeutic Lifestyle Changes in LDL-Lowering Therapy. Major Features TLC Diet Reduced intake of cholesterol-raising nutrients (same as previous Step II Diet) Saturated fats <7% of total calories Dietary cholesterol <200 mg per day

310 views • 7 slides

NCEP ATP III Cholesterol Guidelines and Updates

281 views • 26 slides

More Related